Lir Therapeutics is taking the next leap forward in gene therapy vector engineering

Lir is completely redesigning viral vectors for gene therapy.


Lir Therapeutics is a biotech company that's focused on unlocking the next generation of gene therapy. Our work focuses on viral vector development, with a focus on adeno-associated virus (AAV).

Our aim is to completely redesign AAV, in order to generate therapies that are more effective, safer, and cheaper. Lir's AI-first pipeline combines lab in the loop active learning and therapeutically relevant model design to make changes across the whole virus. We're a team of scientists, bioengineers and AI researchers tackling gene therapy's toughest questions head-on.

We've got big things planned for gene therapy. Watch this space, or reach out to hear about our progress and keep in touch!